SURVEY OF PHYSICIANS INTERACTIONS WITH PHARMACEUTICAL MANUFACTURERS

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
116763	SURVEY OF PHYSICIANS INTERACTIONS WITH PHARMACEUTICAL MANUFACTURERS	Migrated

ICR Details

OMB Control No: 0990-0194	ICR Reference No: 199102-0990-003
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/HHSDM	Agency Tracking No:
Title: SURVEY OF PHYSICIANS INTERACTIONS WITH PHARMACEUTICAL MANUFACTURERS
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 05/24/1991
	Date Received in OIRA: 02/26/1991
Terms of Clearance: Approved for use through 6/92 as a pilot study. In this pilot study, the OIG should refine the questionnaire's design to ensure a higher response rate. In addition, the OIG should thoroughly evaluate non response bias, particularly for the detailed promotion questions. Finally, OMB believes the primary objective of this survey is to describe the range of promotion activities conducted by pharmaceutical manufacturers. The OIG should delete questions B9, P10, R6, and E6 because they do not support this objective and may provide information of questionable validity.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	06/30/1992	06/30/1992
Responses	100	0	0
Time Burden (Hours)	25	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: THIS REQUEST FOR INFORMATION FROM PHYSICIANS ON THEIR INTERACTIONS WIT PHARMACEUTICAL MANUFACTURERS IS NEEDED TO DETERMINE THE EXTENT AND NATURE OF PROMOTIONAL PRACTICES THAT ARE POTENTIALLY VIOLATIVE OF ANTI-KICKBACK REGULATIONS. THE INFORMATION WILL BE USED TO HELP FORMULATE AND INFORM INVESTIGATIVE EFFORTS BY THE OFFICE OF INSPECTOR GENERAL.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
SURVEY OF PHYSICIANS INTERACTIONS WITH PHARMACEUTICAL MANUFACTURERS

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	100	0	0	100	0	0
Annual Time Burden (Hours)	25	0	0	25	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 02/26/1991

---